| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |